Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
4701
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.92M | ﹤0.01% |
227,721
+69,928
| +44% | +$968K |
|
4702
PUT
Constellation Energy
CEG
$100B
| $2.92M | ﹤0.01% |
50,968
-254,016
| -83% | -$15.3M |
|
|
HNGR
4703
DELISTED
Hanger Inc.
HNGR
| $2.92M | ﹤0.01% |
203,741
+117,414
| +136% | +$1.9M |
|
4704
CALL
Kinsale Capital Group
KNSL
$8.64B
| $2.92M | ﹤0.01% |
12,700
-100
| -0.8% | -$22.1K |
|
4705
PUT
Nu Holdings
NU
$73.6B
| $2.92M | ﹤0.01% |
779,700
-3,042,900
| -80% | -$15.4M |
|
4706
PepGen
PEPG
$207M
| $2.92M | ﹤0.01% |
+293,541
| New | +$3.27M |
|
4707
iShares Semiconductor ETF
SOXX
$46.5B
| $2.91M | ﹤0.01% |
25,008
-106,446
| -81% | -$14.4M |
|
4708
Collegium Pharmaceutical
COLL
$875M
| $2.91M | ﹤0.01% |
164,307
+57,782
| +54% | +$972K |
|
4709
iShares MSCI Sweden ETF
EWD
$587M
| $2.91M | ﹤0.01% |
+95,570
| New | +$3.38M |
|
4710
CALL
FuboTV Inc
FUBO
$307M
| $2.91M | ﹤0.01% |
98,192
-1,558
| -2% | -$72.6K |
|
|
NSTG
4711
PUT
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.91M | ﹤0.01% |
229,100
+222,500
| +3,371% | +$4.14M |
|
4712
CALL
Amdocs
DOX
$6.18B
| $2.91M | ﹤0.01% |
34,900
+25,800
| +284% | +$2.13M |
|
|
WE
4713
CALL
DELISTED
WeWork Inc.
WE
| $2.91M | ﹤0.01% |
14,478
+5,448
| +60% | +$1.4M |
|
4714
CALL
iShares National Muni Bond ETF
MUB
$45.8B
| $2.9M | ﹤0.01% |
27,300
+19,600
| +255% | +$2.09M |
|
|
EGRX
4715
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.9M | ﹤0.01% |
65,320
+17,359
| +36% | +$797K |
|
4716
PUT
WD-40
WDFC
$3.08B
| $2.9M | ﹤0.01% |
14,400
+3,100
| +27% | +$579K |
|
4717
CALL
Global E Online
GLBE
$7.12B
| $2.9M | ﹤0.01% |
143,700
-28,500
| -17% | -$655K |
|
4718
CALL
Beam Therapeutics
BEAM
$2.76B
| $2.9M | ﹤0.01% |
74,800
-44,200
| -37% | -$1.76M |
|
|
FBMS
4719
DELISTED
The First Bancshares, Inc.
FBMS
| $2.9M | ﹤0.01% |
101,255
-26,938
| -21% | -$837K |
|
4720
ImmunityBio
IBRX
$8.02B
| $2.89M | ﹤0.01% |
777,981
+438,120
| +129% | +$1.76M |
|
4721
Honda
HMC
$41B
| $2.89M | ﹤0.01% |
119,810
-101,293
| -46% | -$2.59M |
|
4722
V2X
VVX
$2.6B
| $2.89M | ﹤0.01% |
86,467
+36,599
| +73% | +$1.3M |
|
|
FOCS
4723
CALL
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.89M | ﹤0.01% |
84,900
-2,200
| -3% | -$84.1K |
|
|
APLS
4724
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $2.89M | ﹤0.01% |
63,900
-15,100
| -19% | -$688K |
|
4725
ACV Auctions
ACVA
$1.4B
| $2.89M | ﹤0.01% |
441,844
-217,520
| -33% | -$2.24M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.